Thomas Stauffer Larsen

  • Campusvej 55

    5230 Odense M

    Denmark

20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Curriculum

Education

2001: M.D, University of Southern Denmark, Denmark
Academic Degrees and Appointments
2008: Ph.D, University of Southern Denmark, Denmark. ”The JAK2 V617F mutation in Philadelphia chromosome negative chronic myeloproliferative disorders – Impact on clinical phenotype”.
2004-2007: Research Fellow at University of Southern Denmark, Denmark

Clinical Appointments

2001-2003 Resident. Sygehus Fyn Svendborg-Faaborg, Denmark
2003-2004 House Officer. Dept. of Hematology,Odense University Hospital, Denmark.
2008: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark.
2008- 2010: Senior House Officer. Dept. of Internal medicine, Vejle Hospital, Denmark
2010 - 2013: Senior House Officer. Dept. of Hematology, Odense University Hospital, Denmark
2013 - Consultant. Dept. of Haematology, Odense University Hospital, Denmark

Academic Appointments

2013 – Associate Professor of Haematology, Faculty of Medical Sciences, University of Southern Denmark

Relevant positions

Member of the Danish Society of Hematology
Member of board, Danish Studygroup on Chronic Myeloid Disease (DSKMS)
Member of the Nordic MPD Study Group.
Member of European Cooperation in Science and Technology (COST) Biomedicin and
Molecular Biosciences (BMBS) action BM0902 on MPD.
Member of Recommendation board on stem cell transplantation, Danish Society of Hematology.
Head of Board, Danish committee on autologous stem cell transplantation and high dose therapy, Danish Society of Hematology
Member of AgeCare (Academy of Geriatric Cancer Research). An Elite Research
Center at Odense University Hospital

Fingerprint Dive into the research topics where Thomas Stauffer Larsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

Husby, S., Favero, F., Nielsen, C., Sørensen, B. S., Bæch, J., Grell, K., Hansen, J. W., Rodriguez-Gonzalez, F. G., Haastrup, E. K., Fischer-Nielsen, A., Andersen, P., Arboe, B., Sækmose, S. G., Hansen, P. B., Christiansen, I., Clasen-Linde, E., Meldgaard, L., Ebbesen, L. H., Segel, E. K., Josefsson, P. & 6 others, Thorsgaard, M., El-Galaly, T. C., Brown, P., Weischenfeldt, J., Larsen, T. S. & Grønbæk, K., 1. Jan 2020, In : Leukemia.

Research output: Contribution to journalJournal articleResearchpeer-review

  • Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms

    Pedersen, R. K., Andersen, M., Knudsen, T. A., Sajid, Z., Gudmand-Hoeyer, J., Dam, M. J. B., Skov, V., Kjær, L., Ellervik, C., Larsen, T. S., Hansen, D., Pallisgaard, N., Hasselbalch, H. C. & Ottesen, J. T., Mar 2020, In : Cancer Medicine. 9, 6, p. 2039-2051

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • 37 Downloads (Pure)

    Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review

    Jelicic, J., Larsen, T. S., Maksimovic, M. & Trajkovic, G., Jan 2019, In : Critical Reviews in Oncology/Hematology. 133, p. 1-16

    Research output: Contribution to journalReviewResearchpeer-review

  • DATA-DRIVEN ANALYSIS OF JAK2V617F KINETICS DURING INTERFERON-ALPHA2 TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA AND RELATED NEOPLASMS

    Skov, V., Pedersen, R. K., Andersen, M., Knudsen, T. A., Sajid, Z., Gudmand-Hoeyer, J., M.J.B. Dam, M. J. B., Kjær, L., Ellervik, C., Larsen, T. S., Lund Hansen, D., Hasselbalch, H. C. & Ottesen, J. T., 15. Jun 2019.

    Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

    Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma–a nationwide population-based cohort study

    Clausen, M. R., Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M. & d’Amore, F., 3. Jul 2019, In : Leukemia and Lymphoma. 60, 8, p. 1950-1957

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Activities

    SAFETY AND EFFICACY OF THE PD-L1 INHIBITOR DURVALUMAB WITH R-CHOP OR R2-CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH-RISK DLBCL

    Grzegorz S. Nowakowski (Speaker), Wolfgang Willenbacher (Other), R. Greil (Other), Thomas Stauffer Larsen (Guest lecturer), K. Patel (Other), U. Jäger (Other), R.F. Manges (Other), Lorenz Trumper (Guest lecturer), C. Haioun (Other), H Everaus (Other), N. Kalakonda (Other), J. Knoble (Other), Peter de Nully Brown (Other), J.M. Jørgensen (Other), D. Cunningham (Other), N. Domper Rubio (Other), M. Casadebaig (Other), O. Manzke (Other), J. Munoz (Other)
    18. Jun 2019

    Activity: Talks and presentationsConference presentations

    YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS

    S. Leppä (Lecturer), J. Jørgensen (Other), A. Tierens (Other), L. Meriranta , (Other), I. Østlie (Other), Peter de Nully Brown (Other), Unn-Merete Fagerli (Other), Thomas Stauffer Larsen (Other), S. Mannisto (Other), Lars Munksgaard (Other), M Maisenhölder (Other), K Vasala (Other), P Meyer (Other), Mats Jerkeman (Other), Magnus Bjorkholm (Other), Oystein Fluge (Other), Sirkku Jyrkkio (Other), Elisabeth Methner Ralfkiær (Other), S. Spetalen (Other), Marja-Liisa Karjalainen-Lindsberg (Other), H. Holte (Other)
    18. Jun 2019

    Activity: Talks and presentationsConference presentations

    THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

    Trine Alma Knudsen (Lecturer), Dennis Lund Hansen (Other), Lucas Frans Ocias (Other), Ole Weiss Bjerrum (Other), Mette Brabrand (Other), Christina Ellervik (Other), Daniel el Fassi (Other), Mikael Frederiksen (Other), Lasse Kjær (Other), Thomas Kielsgaard Kristensen (Other), Torben A Kruse (Guest lecturer), Hans Torben Mourits-Andersen (Other), Peter Møller (Other), Ulrik Malthe Overgaard (Other), Dustin Andersen Patel (Other), Marianne Tang Severinsen (Other), Vibe Skov (Other), Anders Lindholm Sørensen (Other), Stentoft Jesper (Other), Jørn Starklint (Other), Karin de Stricker (Other), Mads Thomassen (Other), Thomas Stauffer Larsen (Guest lecturer), C Hasselbalc Hans (Other)
    16. Jun 2019

    Activity: Talks and presentationsConference presentations

    Therapeutic monoclonal antibodies in Hematology

    Thomas Stauffer Larsen (Guest lecturer)
    11. Jan 2019

    Activity: Talks and presentationsTalks and presentations in private or public companies

    AgeCare (External organisation)

    Thomas Stauffer Larsen (Chairman)
    2018 → …

    Activity: MembershipMembership of commitees, commissions, boards, councils, associations, organisations, or similar